Early-onset dementia is linked to shorter survival, with the highest mortality risk in patients with frontotemporal dementia, ...

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home ...

Despite encouraging biomarker shifts, oral semaglutide failed to slow cognitive decline in early Alzheimer’s, leading to an early end of the trial extension.

Chris Hemsworth opens up about his father's early-stage Alzheimer's battle in Chris Hemsworth: A Road Trip to Remember ...

A new study suggests you may want to pay better attention to your HDL cholesterol — but not for the reason you might think.

Two large-scale phase 3 trials found that semaglutide did not significantly slow cognitive decline in early-stage Alzheimer’s ...

Choose a calm moment, listen first and give the person time to share how they feel. Here are some other tips on how to help a ...

Hearing loss also predicts a significantly higher risk of dementia, especially in APOE ε4 carriers, highlighting its value as ...

Johnson & Johnson will discontinue the Phase II Auτonomy study of posdinemab after a scheduled review found the anti-tau ...

Researchers found that tau proteins don’t jump straight into forming Alzheimer’s-associated fibrils—first they assemble into ...

"Drains" in the brain, responsible for clearing toxic waste in the organ, tend to get clogged up in people who show signs of ...

We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...